Showing results (391-400 of 577) with videos related to

Sort By:
Pageof 58
Hepatology (Baltimore, Md.)|April 25, 2017
PTEN Down-Regulation Promotes β-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in MiceEkaterina Kachaylo, Christoph Tschuor, Nicolas Calo, et al.
Transplantation Reviews (Orlando, Fla.)|May 1, 2018
Identifying risk profiles in liver transplant candidates and implications for induction immunosuppressionUmberto Cillo, Wolf O Bechstein, Gabriela Berlakovich, et al.
Artificial Organs|October 7, 2025
Integrating Dialysis in Ex Situ Machine Perfusion: A Systematic Review and Meta-Analysis of OutcomesYomna E Dean, Sean Frisbie, James Gaston, et al.
Surgery|November 16, 2019
The potential of machine learning to predict postoperative pancreatic fistula based on preoperative, non-contrast-enhanced CT: A proof-of-principle studyPatryk Kambakamba, Manoj Mannil, Paola E Herrera, et al.
Surgical Endoscopy|May 2, 2024
Full robotic versus open ALPPS: a bi-institutional comparison of perioperative outcomesCristiano Guidetti, Philip C Müller, Paolo Magistri, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 14, 2020
Hypothermic, oxygenated perfusion (HOPE) provides cardioprotection via succinate oxidation prior to normothermic perfusion in a rat model of donation after circulatory death (DCD)Rahel K Wyss, Natalia Méndez Carmona, Maria Arnold, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 3, 2004
Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantationEmiliano Giostra, Gerd A Kullak-Ublick, Walter Keller, et al.
Nanoscale|August 1, 2013
Nanomagnet-based removal of lead and digoxin from living ratsInge K Herrmann, Andrea Schlegel, Rolf Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2016
CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal AdenocarcinomaGiovanni Stracquadanio, Bart Vrugt, Renata Flury, et al.
BMC Cancer|August 12, 2011
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)Stefan Heinrich, Bernhard Pestalozzi, Mickael Lesurtel, et al.
Pageof 58